FDA Inspection
Noble Panacea Labs, Inc.Noble Panacea Labs, Inc. – FDA Inspection, Nov 8, 2024
Record Details
This FDA Inspection record concerns Noble Panacea Labs, Inc., with an inspection on November 8, 2024, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · c6070160-5570-4706-8a65-603a0549b32e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1254756
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
11- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.188(b)(8)Labeling control records including specimens or copies
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.48(a)Plumbing System Defects
- 21 CFR 211.25(c)Inadequate number of personnel
- 21 CFR 211.160(b)(1)Retesting
- 21 CFR 211.170(b)Reserve drug product sample quantity - all tests
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.100(a)Absence of Written Procedures
Showing 10 of 11 citations.
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.